pCI-neo beta catenin delta45 Citations (4)

Originally described in: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.
Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW Science. 1997 Mar 21. 275(5307):1787-90. PubMed Journal

---

Articles Citing pCI-neo beta catenin delta45

Articles
Dickkopf 4 (DKK4) acts on Wnt/beta-catenin pathway by influencing beta-catenin in hepatocellular carcinoma. Fatima S, Lee NP, Tsang FH, Kolligs FT, Ng IO, Poon RT, Fan ST, Luk JM. Oncogene. 2012 Sep 20;31(38):4233-44. doi: 10.1038/onc.2011.580. Epub 2012 Jan 16. PubMed
Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/beta-catenin signaling. Leung CO, Mak WN, Kai AK, Chan KS, Lee TK, Ng IO, Lo RC. Oncotarget. 2016 May 17;7(20):29371-86. doi: 10.18632/oncotarget.8835. PubMed
Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/beta-catenin pathway. Lo RC, Leung CO, Chan KK, Ho DW, Wong CM, Lee TK, Ng IO. Cell Death Differ. 2018 Aug;25(8):1426-1441. doi: 10.1038/s41418-018-0059-x. Epub 2018 Feb 14. PubMed
Targeting beta-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations. Moon JH, Hong SW, Kim JE, Shin JS, Kim JS, Jung SA, Ha SH, Lee S, Kim J, Lee DH, Park YS, Kim DM, Park SS, Hong JK, Kim DY, Kim EH, Jung J, Kim MJ, Kim SM, Deming DA, Kim K, Kim TW, Jin DH. Br J Cancer. 2019 Apr;120(9):941-951. doi: 10.1038/s41416-019-0434-5. Epub 2019 Apr 4. PubMed

If you have published an article using this material, please email us at to have your article added to this page.